Our studies have provided novel finding that B3GALT5 plays a role in facilitating lymph node and lung metastasis through β-catenin/ZEB1 pathway, suggesting B3GATL5 might be potential target for tackling BCSCs, cell proliferation, and EMT in breast cancer. Here, B3GALT5 is linked to breast cancer.